Inhibition of spontaneous platelet aggregation by sulfinpyrazone
- PMID: 505369
Inhibition of spontaneous platelet aggregation by sulfinpyrazone
Abstract
In a randomized double-blind crossover study in 16 patients with enhanced in vitro spontaneous platelet aggregation, sulfinpyrazone proved to be effective in normalizing platelet aggregability within 4 days after initiation of therapy.